SUNSHINE BIOPHARMA INC (SBFM) Stock News

NASDAQ:SBFM - Nasdaq - US8677817004 - Common Stock - Currency: USD

1.52 +0.01 (+0.66%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

SBFM Latest News, Press Relases and Analysis

All

Press Releases

14 days ago - By: Benzinga - Mentions: CNC GNTA SNGX SCNI ...

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

14 days ago - By: ACCESS Newswire

Sunshine Biopharma Launches NIOPEG(R) Into $10 Billion Biologics Market

a month ago - By: ACCESS Newswire

Sunshine Biopharma Launches Generic Gabapentin for Neuropathic Pain in the Canadian Segment of the Global $1.92 Billion Market

2 months ago - By: ACCESS Newswire

Sunshine Biopharma Reports 2025 First Quarter Results, Revenues Up 18% Over Same Period Last Year

2 months ago - By: ACCESS Newswire

Sunshine Biopharma Launches Generic Lurasidone for Schizophrenia in the Canadian Sector of the Global $1.2 Billion Market

3 months ago - By: ACCESS Newswire

Sunshine Biopharma Launches Everolimus In Canada, an Oncology Drug with an Estimated Global Market of $2.5 Billion

3 months ago - By: Benzinga - Mentions: PRPH RDHL APVO PRTG ...

12 Health Care Stocks Moving In Monday's Pre-Market Session

3 months ago - By: ACCESS Newswire

Sunshine Biopharma Inc. Announces Closing of $2.46 Million Registered Direct Offering

4 months ago - By: ACCESS Newswire

Sunshine Biopharma Inc. Announces $2.46 Million Registered Direct Offering Priced at the Market Under Nasdaq Rules

4 months ago - By: ACCESS Newswire

Sunshine Biopharma Announces Positive Results of mRNA Therapy for Cancer

4 months ago - By: ACCESS Newswire

Sunshine Biopharma Reports Revenue of $34.9M in Fiscal 2024, Up 45% From Last Year

4 months ago - By: ACCESS Newswire

Sunshine Biopharma Expands Presence in the $53.9 Billion Global Antibiotics Market with the Acquisition of Marketing Rights for Two New Antibiotics in Canada

4 months ago - By: ACCESS Newswire

Sunshine Biopharma Acquires Rights to Launch Two Gastrointestinal Drugs in the Canadian $200 Million Market

6 months ago - By: ACCESS Newswire

Sunshine Biopharma Expands Its Product Line to 69 Generic Prescription Drugs by Launching Olanzapine and Olanzapine ODT

11 months ago - By: FN Media Group LLC - Mentions: NVAX RGNX BNTX ABBV

New Research Reveals Emergence of New Variants of Coronavirus to Boost COVID-19 Therapeutics Market Growth

11 months ago - By: FN Media Group LLC - Mentions: MRNA PFE VIR INO

Global Coronavirus Therapeutics Market Size Projected to Exceed $16 Billion By the End of 2031